Order Article Reprints

Wijnands C, Karel PGA, Gloerich J, Armony G, Tzasta A, de Kat Angelino CM, Di Stefano L, Bonifay V, Luider TM, VanDuijn MM, et al. Monitoring M-Protein, Therapeutic Antibodies, and Polyclonal Antibodies in a Multiparametric Mass Spectrometry Assay Provides Insight into Therapy Response Kinetics in Patients with Multiple Myeloma. Pharmaceutics. 2025; 17(1):135. https://doi.org/10.3390/pharmaceutics17010135

Wijnands, Charissa, Peter G. A. Karel, Jolein Gloerich, Gad Armony, Anastasia Tzasta, Corrie M. de Kat Angelino, Luciano Di Stefano, Vincent Bonifay, Theo M. Luider, Martijn M. VanDuijn, and et al. 2025. "Monitoring M-Protein, Therapeutic Antibodies, and Polyclonal Antibodies in a Multiparametric Mass Spectrometry Assay Provides Insight into Therapy Response Kinetics in Patients with Multiple Myeloma" Pharmaceutics 17, no. 1: 135. https://doi.org/10.3390/pharmaceutics17010135

Wijnands, C., Karel, P. G. A., Gloerich, J., Armony, G., Tzasta, A., de Kat Angelino, C. M., Di Stefano, L., Bonifay, V., Luider, T. M., VanDuijn, M. M., Croockewit, S. J., de Kort, E. A., Castelijn, D. A. R., Stege, C. A. M., Wessels, H. J. C. T., van Gool, A. J., van de Donk, N. W. C. J., & Jacobs, J. F. M. (2025). Monitoring M-Protein, Therapeutic Antibodies, and Polyclonal Antibodies in a Multiparametric Mass Spectrometry Assay Provides Insight into Therapy Response Kinetics in Patients with Multiple Myeloma. Pharmaceutics, 17(1), 135. https://doi.org/10.3390/pharmaceutics17010135